HLA-DR Antigens

"HLA-DR Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS.

Descriptor ID	D006684
MeSH Number(s)	D12.776.395.550.509.400.440 D12.776.543.550.440.400.440 D23.050.301.500.400.400.440 D23.050.301.500.450.400.440 D23.050.705.552.410.400.440 D23.050.705.552.450.400.440
Concept/Terms	HLA-DR Antigens HLA-DR Antigens Antigens, HLA-DR HLA DR Antigens HLA-DR

Below are MeSH descriptors whose meaning is more general than "HLA-DR Antigens".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Glycoproteins [D12.776.395]
Membrane Glycoproteins [D12.776.395.550]
Histocompatibility Antigens Class II [D12.776.395.550.509]
HLA-D Antigens [D12.776.395.550.509.400]
HLA-DR Antigens [D12.776.395.550.509.400.440]
Membrane Proteins [D12.776.543]
Membrane Glycoproteins [D12.776.543.550]
Histocompatibility Antigens Class II [D12.776.543.550.440]
HLA-D Antigens [D12.776.543.550.440.400]
HLA-DR Antigens [D12.776.543.550.440.400.440]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Histocompatibility Antigens [D23.050.301.500]
Histocompatibility Antigens Class II [D23.050.301.500.400]
HLA-D Antigens [D23.050.301.500.400.400]
HLA-DR Antigens [D23.050.301.500.400.400.440]
HLA Antigens [D23.050.301.500.450]
HLA-D Antigens [D23.050.301.500.450.400]
HLA-DR Antigens [D23.050.301.500.450.400.440]
Isoantigens [D23.050.705]
Histocompatibility Antigens [D23.050.705.552]
Histocompatibility Antigens Class II [D23.050.705.552.410]
HLA-D Antigens [D23.050.705.552.410.400]
HLA-DR Antigens [D23.050.705.552.410.400.440]
HLA Antigens [D23.050.705.552.450]
HLA-D Antigens [D23.050.705.552.450.400]
HLA-DR Antigens [D23.050.705.552.450.400.440]

Below are MeSH descriptors whose meaning is related to "HLA-DR Antigens".

Below are MeSH descriptors whose meaning is more specific than "HLA-DR Antigens".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HLA-DR Antigens" by people in this website by year, and whether "HLA-DR Antigens" was a major or minor topic of these publications.

Bar chart showing 16 publications over 12 distinct years, with a maximum of 2 publications in 2002 and 2006 and 2008 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2001	1	0	1
2002	0	2	2
2004	0	1	1
2006	0	2	2
2007	0	1	1
2008	2	0	2
2011	0	1	1
2016	0	1	1
2018	0	1	1
2022	0	1	1
2023	1	1	2

Below are the most recent publications written about "HLA-DR Antigens" by people in Profiles.

Rosado MRS, Marzan-Rivera N, Watowich MM, Valle ADN, Pantoja P, Pavez-Fox MA, Siracusa ER, Cooper EB, Valle JEN, Phillips D, Ruiz-Lambides A, Martinez MI, Montague MJ, Platt ML, Higham JP, Brent LJN, Sariol CA, Snyder-Mackler N. Immune cell composition varies by age, sex and exposure to social adversity in free-ranging Rhesus Macaques. Geroscience. 2024 04; 46(2):2107-2122.

View in: PubMed
Wigerblad G, Warner SA, Ramos-Benitez MJ, Kardava L, Tian X, Miao R, Reger R, Chakraborty M, Wong S, Kanthi Y, Suffredini AF, Dell'Orso S, Brooks S, King C, Shlobin O, Nathan SD, Cohen J, Moir S, Childs RW, Kaplan MJ, Chertow DS, Strich JR. Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19. Sci Adv. 2023 01 04; 9(1):eade8272.

View in: PubMed
Shikuma CM, Le T, Phuong TV, Chew GM, Nguyen VVC, Vo TL, Siriwardhana C, Chow D, Ghukasyan H, Limpruttidham N, Premeaux T, Gangcuangco LM, Paul R, Ndhlovu LC. Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam. AIDS Res Hum Retroviruses. 2022 06; 38(6):441-450.

View in: PubMed
Ghoneum MH, Ogura T, Gimzewski JK, Ghoneum AD, Henary MC, Agrawal S. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro. Int J Immunopathol Pharmacol. 2018 Jan-Dec; 32:2058738418797768.

View in: PubMed
Riangwiwat T, Kohorn LB, Chow DC, Souza SA, Ndhlovu LC, Wong JW, Gangcuangco LM, Shikuma CM. CD4/CD8 Ratio Predicts Peripheral Fat in HIV-Infected Population. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):e17-9.

View in: PubMed
Cantor JR, Yoo TH, Dixit A, Iverson BL, Forsthuber TG, Georgiou G. Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci U S A. 2011 Jan 25; 108(4):1272-7.

View in: PubMed
Abbas M, Bobo LD, Hsieh YH, Berka N, Dunston G, Bonney GE, Apprey V, Quinn TC, West SK. Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1734-8.

View in: PubMed
Kawamura K, McLaughlin KA, Weissert R, Forsthuber TG. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J Immunol. 2008 Sep 01; 181(5):3202-11.

View in: PubMed
Fern?ndez M, Alarc?n GS, Calvo-Al?n J, Andrade R, McGwin G, Vil? LM, Reveille JD. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007 May 15; 57(4):576-84.

View in: PubMed
Macaubas C, Wahlstrom J, Galv?o da Silva AP, Forsthuber TG, S?nderstrup G, Kwok WW, DeKruyff RH, Umetsu DT. Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol. 2006 Apr 15; 176(8):5069-77.

View in: PubMed

People

Explore

Similar Concepts

Top Journals